GENEVA, May 18 -- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD (Zone A, 4F, 289 Digitland, 2 Hongliu Road, Futian DistrictShenzhen, Guangdong 518017), 深圳信立泰药业股份有限公司 (中国广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区) filed a patent application (PCT/CN2025/132792) for "PCSK9 CYCLIC PEPTIDE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Nov 05, 2025. With publication no. WO/2026/098515, the details related to the patent application was published on May 15, ...